cis-3-Hexenyl trans-2-hexenoate
Common Name: |
cis-3-Hexenyl trans-2-hexenoate |
IUPAC Name: |
[(Z)-hex-3-enyl] (E)-hex-2-enoate |
Molecular Formula: |
C12H20O2 |
SMILES: |
CCCC=CC(=O)OCCC=CCC |
Inchi: |
1S/C12H20O2/c1-3-5-7-9-11-14-12(13)10-8-6-4-2/h5,7-8,10H,3-4,6,9,11H2,1-2H3/b7-5-,10-8+ |
Inchi Key: |
WAZKUHYKUCORDK-SUTBWYPISA-N |
Cas No: |
53398-87-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
196.29 |
Mass (g/mol) |
196.146 |
Molar Refractivity |
60.13 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
8 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
114.00 to 115.00 @ 15.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.01 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.58 |
LogP |
3.242 |
iLOGP |
3.11 |
XLOGP3 |
3.68 |
WLOGP |
3.24 |
MLOGP |
2.95 |
ESOL Log S |
-2.85 |
ESOL Solubility (mg/ml) |
0.279 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.92 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.55 |
Silicos-IT Solubility (mg/ml) |
0.55 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.88 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.875 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.909 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |